Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Cash from Investing Activities (2024 - 2025)

BioScience Health Innovations (BHIC) has disclosed Cash from Investing Activities for 2 consecutive years, with -$10786.0 as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 43.23% to -$10786.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$56850.0 through Dec 2025, down 118.34% year-over-year, with the annual reading at -$56850.0 for FY2025, 118.34% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$10786.0 at BioScience Health Innovations, up from -$16064.0 in the prior quarter.
  • The five-year high for Cash from Investing Activities was -$7037.0 in Q3 2024, with the low at -$30000.0 in Q1 2025.